首页> 外文期刊>Biochimie >Biochemical properties and cellular localization of Plasmodium falciparum protein disulfide isomerase
【24h】

Biochemical properties and cellular localization of Plasmodium falciparum protein disulfide isomerase

机译:恶性疟原虫蛋白二硫键异构酶的生化特性和细胞定位

获取原文
获取原文并翻译 | 示例
           

摘要

We have previously reported the isolation of a 52,000 M_r protein (Pf52) displaying consensus sequences for thiol:disulfide oxidoreductases. Pf52 therefore represents the plasmodial protein disulfide isomerase (PDI). It has been renamed PfPDI and correlates to MAL8P1.17 in the annotated genome of P. falciparum (3D7 strain). Antibodies were raised against recombinant (His)_6-tagged forms of PfPDI devoid of its signal peptide sequence, demonstrating a major co-localization of PfPDI with endoplasmic reticulum-resident proteins, PfBIP and PfERC, but not with the Golgi marker PfERD2. Recombinant PfPDI displayed typical biochemical functions of PDIs: oxidase/isomerase and reductase activities, as well as a chap-erone-like behavior on the denaturated protein rhodanese. These activities were comparable to those measured for the purified native bovine PDI and the human recombinant PDI. The antiplasmodial compound DS61 does inhibit the recombinant PfPDI oxidase/isomerase activity but not that of the human recombinant PDI, suggesting structural differences between both enzymes. However, a discrepancy between the inhibitory activity of DS61 on the recombinant PfPDI (IC_(50) of 430 μM) and its in vitro antiplasmodial activity (IC_(50) of 0.1 μM) was observed, suggesting that PfPDI is not the only target of DS61. Taking into account its biochemical properties and its intracellular localization, the involvement of PfPDI in the parasite protein folding is discussed, as well as its potential for the development of alternative antimalarial chemotherapy strategies.
机译:我们以前曾报道过分离出52,000个M_r蛋白(Pf52),该蛋白显示了硫醇:二硫键氧化还原酶的共有序列。因此,Pf52代表质膜蛋白二硫键异构酶(PDI)。它已重命名为PfPDI,并与恶性疟原虫(3D7株)的注释基因组中的MAL8P1.17相关。产生了针对没有其信号肽序列的重组(His)-6标签形式的PfPDI的抗体,这表明PfPDI与内质网驻留蛋白PfBIP和PfERC存在主要的共定位作用,但与高尔基体标记PfERD2没有共同作用。重组PfPDI表现出PDI的典型生化功能:氧化酶/异构酶和还原酶活性,以及​​变性蛋白花丹丹上类似Chap-Eerone的行为。这些活性与纯化的天然牛PDI和人重组PDI的活性相当。抗疟原虫化合物DS61确实抑制重组PfPDI氧化酶/异构酶活性,但不抑制人重组PDI的活性,表明这两种酶之间的结构差异。但是,观察到DS61对重组PfPDI的抑制活性(IC_(50)为430μM)与其体外抗血浆活性(IC_(50)为0.1μM)之间存在差异,这表明PfPDI并非唯一的靶标。 DS61。考虑到其生化特性及其在细胞内的定位,讨论了PfPDI与寄生虫蛋白折叠的关系,以及其在开发其他抗疟疾化学疗法中的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号